Traves PG, Murray B, Campigotto F, Galien R, et al. JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib. Ann Rheum Dis 2021;80:865-875.
PMID: 33741556